跳至主要内容
临床试验/KCT0009357
KCT0009357进行中(未招募)Unknown

Safety and Effectiveness of pravastatin in Korean patients with dyslipidemia based on the cardiovascular risk classification: Pooled analysis of 4 observational studies

Daiichi-Sankyo Korea0 个研究点目标入组 15,475 人开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
15,475

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18(Year) 至 o Limit(—)
性别
All

入选标准

  • 1. Males or females aged = 65 years with a diagnosis of dyslipidemia
  • 2. Patients who were prescribed Mevalotin® in the judgment of their physicians, or who started receiving Mevalotin® tab. within 6 weeks from enrollment in this observational study
  • 3. Voluntary written consent to participation in this observational study by the patients or their representatives

排除标准

  • 1. Subjects who were enrolled even though they violated the prior study's inclusion/exclusion criteria
  • 2. Subjects who took another statin drug before participating in prior studies.
  • 3. Subjects who took pravastatin 5 mg or 10 mg

研究者

发起方
Daiichi-Sankyo Korea

相似试验